This report is prepared for the Warsaw Stock Exchange SA within the framework of the Analytical Coverage Support Program 3.0.
Event: Buyback update
The Company informed that it purchased 141,700 shares (3.3% of the share capital) for PLN 4.0 million in the pending buyback which implies an average price per share at c. PLN 28.32. BioMaxima has spent already 80% of the amount earmarked for the buyback (PLN 5 million).
Expected impact: Neutral.
Analyst
Sylwia Jaśkiewicz, CFA
Mikołaj Stępień